M.D. Anderson Cancer Center - Expanded Access Programs

Expanded Access Intelligence

Official Statements

Score contribution: 100 — 1 supporting sources.

Score 1001 references

Featured Reference

“What if I have an expanded access use/request for an unapproved drug, biologic or device? Expanded access is a specific pathway for a patient with an immediately life-threatening condition or serious disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.”

EAP Related Articles from Sponsor

Score contribution: 80 — 6 supporting sources.

Score 806 references

Featured Reference

Clinical TrialsOpens in new window

[2020-0660](https://clinicaltrials.gov/ct2/show/NCT04400591) Expanded access protocol (eap) for patients receiving lisocabtagene maraleucel that is nonconforming for commercial release

Fecal transplant effective against immunotherapy-induced colitisSource

The researchers chose to investigate the potential for FMT as an alternative, compassionate-use therapy for patients suffering from refractory, or unresponsive, ICI-associated colitis. The two patients included in the study were treated at MD Anderson between June 2017 and January 2018. ... FMT continues to be offered to MD Anderson patients on a compassionate-use basis.

Clinical TrialsSource

**[2019-0481:](https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2019-0481.html)** Expanded Access Protocol: Umbilical Cord Blood Infusions for Children with Brain Injuries (PI: Kris Mahadeo, MD, MPH) **[2019-0079:](https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2019-0079.html)** Expanded Access Protocol for Providing Tabelecleucel to Patients With Epstein-Barr Virus-Associated Viremia or Malignancies for Whom There are No Appropriate Alternative Therapies (PI: Kris Mahadeo, MD, MPH)

Cancer Network PartnersSource

- Expanded access to research and clinical trials

Breast surgery fellow: Why my coronavirus diagnosis led me to donate plasmaSource

MD Anderson is participating in a national FDA expanded access initiative led by the Mayo Clinic to provide plasma from recovered patients to patients currently facing the disease, and I wanted to do my part.

Lenvatinib brings thyroid cancer patient hopeSource

"Early access to new therapies" Now that the drug's approved, patients everywhere can benefit. "But our patients get the chance to benefit much earlier because we test new drugs," Hong says.

Partner with Right2Hope

Right2Hope helps sponsors translate regulatory programs into actionable patient access pathways. Connect with our team to publish new programs, streamline intake workflows, or align with providers seeking compassionate use options.

Talk to Our Team Explore Programs